RIZZO, MICHELANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.428
EU - Europa 2.191
AS - Asia 1.419
SA - Sud America 269
AF - Africa 69
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.437
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.392
RU - Federazione Russa 1.032
SG - Singapore 490
IE - Irlanda 340
HK - Hong Kong 330
SE - Svezia 311
CN - Cina 235
BR - Brasile 226
KR - Corea 191
IT - Italia 111
FI - Finlandia 98
UA - Ucraina 73
DE - Germania 69
GB - Regno Unito 68
IN - India 61
AU - Australia 59
CI - Costa d'Avorio 47
CH - Svizzera 43
VN - Vietnam 35
CA - Canada 23
AR - Argentina 16
TR - Turchia 15
BD - Bangladesh 12
FR - Francia 12
EC - Ecuador 11
IQ - Iraq 10
JP - Giappone 9
PL - Polonia 9
PE - Perù 7
MX - Messico 6
NL - Olanda 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
SC - Seychelles 4
BH - Bahrain 3
PK - Pakistan 3
PY - Paraguay 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CD - Congo 2
CO - Colombia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ES - Italia 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
MU - Mauritius 2
NP - Nepal 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
VE - Venezuela 2
AL - Albania 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
SN - Senegal 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.437
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.757
Dublin 340
Chandler 306
Hong Kong 253
Singapore 251
Fairfield 232
Seoul 184
Ashburn 138
Buffalo 131
Jacksonville 115
Woodbridge 109
Cambridge 108
Dallas 93
Seattle 92
Wilmington 88
Princeton 86
Beijing 83
Boston 83
Houston 65
Boardman 63
Melbourne 58
Ann Arbor 57
Abidjan 47
Mumbai 45
Bern 43
Los Angeles 43
Hefei 35
Moscow 28
Medford 24
Redondo Beach 23
Shanghai 21
Falls Church 20
Munich 20
The Dalles 18
Toronto 16
São Paulo 14
Kent 13
Andover 12
San Diego 12
Hillsboro 10
Lawrence 10
New York 10
Norwalk 10
Brooklyn 9
Florence 9
Ho Chi Minh City 9
Tokyo 9
Frankfurt am Main 8
Milan 8
Warsaw 8
Altamura 7
Izmir 7
Portsmouth 7
Rio de Janeiro 7
Turku 7
Guayaquil 6
Hanoi 6
Lima 6
London 6
Montreal 6
Tianjin 6
Yubileyny 6
Brasília 5
Brussels 5
Campo Grande 5
Dhaka 5
Manchester 5
Paris 5
San Francisco 5
San Marzano di San Giuseppe 5
Atlanta 4
Casablanca 4
Curitiba 4
Denver 4
Erbil 4
Helsinki 4
Porto Alegre 4
Stockholm 4
West Jordan 4
Amsterdam 3
Belo Horizonte 3
Bengaluru 3
Campinas 3
Changsha 3
Chicago 3
Council Bluffs 3
Da Nang 3
Duncan 3
Gravataí 3
Johannesburg 3
Laurel 3
Lauterbourg 3
Lewisham 3
Maletto 3
Marília 3
Quito 3
Recife 3
Redwood City 3
Ribeirão Preto 3
Salerno 3
Totale 5.442
Salva come PNG Salva come JPEG
Nome #
M-VEC chemotherapy: new perspectives in the treatment of bladder cancer 169
Imperative indications for conservative surgery for renal cell carcinoma: 20 years' experience. 166
Localization of endothelin-converting enzyme-1 in human kidney 165
The role of lomefloxacin in the treatment of chronic prostatitis. 163
Computerized in vivo research from the growth of urease-producing bacteria in the presence of antibiotics combined with propionhydroxamic acid 144
Complete androgen blockade as treatment for advanted prostate cancer: clinical response and side-effects 137
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 133
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 133
A combination of chemotherapy with M-VEC (methotrexate, vinblastine, epirubicin, cisplatin) in the treatment of metastatic carcinoma of the bladder [POLICHEMIOTERAPIA CON M-VEC (METOTRESSATO, VINBLASTINA, EPIRUBICINA, CISPLATINO) NEL TRATTAMENTO DEI PAZIENTI CON CARCINOMA VESCICALE METASTATICO] 129
Antibacterial activity of succinyl-norfloxacin in urinary infections: a comparative study 125
Apparato Urogenitale 124
A phase III study of recombinant leukocyte alpha Inteferon and Vinblastine in metastatic renal cell carcinoma. Preliminary report. 124
Anomalie di sviluppo 124
Early diagnosis and monitoring of superficial transitional call carcinoma by microsatellite analysis on urine sediment 123
Ureteral intussusception by a fibroepithelial polyp. 123
Conservative surgery of renal cell carcinoma: a retrospective analysis of 25 years of experience 123
Alterazioni della minzione 123
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 122
Anomalie di sviluppo 122
Alterazioni della minzione 122
URINARY SYMPTOMS, QUALITY OF LIFE AND SEXUAL FUNCTION IN PATIENTS WITH BENIGN PROSTATIC HYPERTROPHY BEFORE AND AFTER PROSTATECTOMY: A PROSPECTIVE STUDY 121
Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up. 121
ADAPTIVE MORPHOLOGICAL CHANGES OF THE INTESTINAL MUCOSA IN ORTHOTOPIC ILEAL BLADDERS. SHORT-TERM AND LONG-TERM EVALUATION. 120
Apparato Urogenitale 119
Calcolosi urinaria 118
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 117
Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer 115
Leiomyoma of the corona glans penis. 113
Epidemiology and risk factors in urolithiasis 113
Benign prostate hypertrophy and sexual activity: evaluation of prostate symptoms (IPSS) and erectile function (IIEF). 110
Long-term results of anterior and posterior urethroplasty with actuarial evaluation of the success rates 109
Surgical treatment of bilateral large seminal vesicle cysts associated with unilateral renoureteral agenesis 107
P53 gene mutations in transitional cell bladder carcinoma. 107
Calcolosi urinaria 105
The psoas bladder Hitch procedure in ureter lesions [LA PSOAS BLADDER HITCH NELL LESIONI DELL'URETERE] 105
Pathophysiology of reno-ureteral colic 105
Giant stone in enterocystoplasty 103
Patologia dell'apparato genitale maschile 103
cisti e lesioni vascolari 102
Surgical repair of extensive ureteral loss by renal autotransplantation 99
The role of molecular biology in bladder and prostatic carcinoma 99
Urethral carcinoma recurrence in ileal orthotopic neobladder:urethrectomy and conversion in a continent pouch with abdominal stoma 98
Ureterouterine fistula as a complication of cesarean section 97
Biology and paraneoplastic syndromes of renal carcinoma [BIOLOGIA E SINDROMI PARANEOPLASTICHE DEL CARCINOMA RENALE] 95
Natural history of renal cell carcinoma 94
Cisti e lesioni vascolari 93
Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up. 91
The treatment of primary neoplasm of the ureter. A review of sixty cases [IL TRATTAMENTO DELLE NEOPLASIE PRIMITIVE DELL'URETERE: REVISIONE DI 60 CASI] 89
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. 87
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections 85
Infezioni delle vie urinarie 80
Morphologic evaluation of urinary stones in patients with recurrent stone formation [VALUTAZIONE MORFOLOGICA DEI CALCOLI URINARI NEI PAZIENTI ABITUALI FORMATORI DI CALCOLI] 80
Traumi dell'apparato urogenitale 79
Incidental prostatic carcinoma after suprapubic prostatectomy: Clinical and pathological evaluation 77
Therapy of uncomplicated urogenital infections: Comparative study between norfloxacin, enoxacin and ofloxacin [TERAPIA DELLE INFEZIONI URO-GENITALI NON COMPLICATE: STUDIO COMPARATIVO APERTO FRA NORFLOXACINA, ENOXACINA ED OFLOXACINA] 77
Recurrent calcium nephrolithiasis: Variations in the structure and growth of urinary crystals [NEFROLITIASI CALCICA RECIDIVANTE: VARIAZIONI NELLA STRUTTURA E NELLA CRESCITA DEI CRISTALLI URINARI] 76
Correlations between cytogenetic analysis and static cytometry in renal carcinoma [CORRELAZIONI FRA ANALISI CITOGENETICA E CITOMETRIA STATICA NEL CARCINOMA RENALE] 75
Interferon alpha 2A in superficial bladder cancer prophylaxis: toleration and long-term follow-up. A phase I-II study 74
Lesioni ostruttive 74
Interferon alpha 2 a and vinblastine in th treatment of metastatic renal carcinoma 74
Neo-adjuvant M-VEC chemotherapy in the treatment of bladder cancer: our experience on 12 patients 73
Conservative surgery of renal cell carcinoma: Evaluation of the prognostic factors 73
Intravesical immunotherapy with alpha 2A Interferon in patients with superficial bladder tumors. 73
Tumori dell'apparato urinario 73
The role of interferons in the treatment of urinary tract cancer [IL RUOLO DEGLI INTERFERONI NEL TRATTAMENTO DELLE NEOPLASIE UROLOGICHE] 72
Somatomedin C in the seminal plasma of subjects with azoospermia 72
Leuprolide depot in treatment of advanced prostatic carcinoma: a dose related clinical and endocrinological evaluation. 72
Lesioni ostruttive 72
Il trapianto renale nei pazienti a rischio 71
Patologia dell'apparto genitale maschile 71
Mepartricin in the treatment of benign prostatic diseases: Four years experience 71
Intravesical immunotherapy with alpha 2A Interferon in patients with superficial bladder tumors. 71
Painless non invasive lithotripsy of pelvic and iuxtavesical ureteral stones 71
Correlations between multiple rectal examination, PSA, transrectal echography and Gleason score in the screening of suspected prostatic carcinoma [CORRELAZIONI FRA ESPLORAZIONE RETTALE MULTIPLA, PSA, ECOGRAFIA TRANSRETTALE E GLEASON SCORE NELLO SCREENING DEL NODULO PROSTATICO SOSPETTO] 70
Vascular disease, trauma and infections of the retroperitoneum (except retroperitoneal fibrosis) [PATOLOGIA VASCOLARE, TRAUMATICA E SINDROMI INFIAMMATORIE DEL RETROPERITONEO (ESCLUSA LA FIBROSIS RETROPERITONEALE)] 69
Intra-operative antibiotic perfusion in the renal artery in patients with infection induced staghorn calculi 69
Modulation of the role of androgens in the production of growth factor receptors in the prostatic tissue of men with prostate hyperplasia [MODULAZIONE DA PARTE DEGLI ANDROGENI DELLA PRODUZIONE DI RECETTORI PER I FATTORI DI ACCRESCIMENTO NEL TESSUTO PROSTATICO DI PROSTATE IPERPLASTICHE] 68
Renal autotransplantation in reconstructive surgery of the ureter [L'AUTOTRAPIANTO RENALE NELLA CHIRURGIA RIPARATIVA DELL'URETERE] 68
Intravesical antiblastic prophylaxis: Inteferon alpha . 4 epidoxorubicin versus 4 epidoxorubicin. Results of a randomized study [PROFILASSI ANTIBLASTICA ENDOVESCICALE: INTEFERONE ALFA + 4 EPIDOXORUBICINA VERSUS 4 EPIDOXORUBICINA. RISULTATI DI UNO STUDIO RANDOMIZZATO] 68
The role of recombinant Interferon alpha 2 A in endocavitary prophylaxis of superficial bladder tumors. 68
Infezioni delle vie urinarie 66
Tumori dell'apparato urinario 66
The role of fluoro-deoxyuridine (FUDR) in continuous circadian administration in the therapy of metastatic renal carcinoma: Our experience in 10 cases [IL RUOLO DELLA FLUORODESOSSIURIDINA (FUDR) IN SOMMINISTRAZIONE CIRCADIANA CONTINUA NELLA TERAPIA DEL CARCINOMA RENALE METASTATICO: NOSTRA ESPERIENZA SU 10 CASI] 65
Traumi dell'apparato urogenitale 65
Prostatectomia radicale retropubica nerve sparing: modifiche di tecnica 65
Frequently isolated uropathogenic strains and antibiotic resistance: An essential basis to a rational therapeutic approach in urinary tract infections [FREQUENZA DI ISOLAMENTO DEI GERMI UROPATOGENI ED ANTIBIOTICORESISTENZA: PREMESSE INDISPENSABILI AD UN APPROCCIO TERAPEUTICO RAZIONALE DELLE INFEZIONI URINARIE] 64
null 43
Totale 8.449
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.400
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.400
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021278 0 0 0 0 0 83 12 26 40 55 43 19
2021/2022454 2 69 1 25 12 9 10 25 14 8 101 178
2022/20231.177 150 80 44 75 110 255 186 82 105 5 32 53
2023/2024350 14 60 92 29 15 36 6 52 3 11 15 17
2024/20253.725 120 327 203 430 1.407 611 44 224 145 57 85 72
2025/20261.435 291 442 230 160 304 8 0 0 0 0 0 0
Totale 8.449